Skin cancer and COVID-19.
作者信息
Goldust Mohamad, Agarwal Komal, Podder Indrashis, Navarini Alexander A
机构信息
Department of Dermatology & Allergy, University Hospital of Basel, Basel, Switzerland.
Department of Dermatology, CNMC, Kolkata, India.
出版信息
Dermatol Ther. 2020 Nov;33(6):e14050. doi: 10.1111/dth.14050. Epub 2020 Sep 7.
Abstract
摘要
相似文献
1
Skin cancer and COVID-19.
Dermatol Ther. 2020 Nov;33(6):e14050. doi: 10.1111/dth.14050. Epub 2020 Sep 7.
2
The magnitude of COVID-19's effect on the timely management of melanoma and nonmelanoma skin cancers.
J Am Acad Dermatol. 2021 Apr;84(4):1100-1103. doi: 10.1016/j.jaad.2020.12.065. Epub 2021 Jan 19.
3
COVID-19 infection in patients with Sézary syndrome: Report of two cases.
Dermatol Ther. 2020 Nov;33(6):e14042. doi: 10.1111/dth.14042. Epub 2020 Aug 13.
4
COVID-19 and skin cancer management: French nation-wide questionnaire survey from real-life practice.
J Dermatolog Treat. 2022 Mar;33(2):1200-1201. doi: 10.1080/09546634.2020.1801972. Epub 2020 Aug 24.
5
Coincidental SARS-CoV-2 infection and mRNA vaccination: a case report addressing the most important clinical questions.
Infection. 2021 Aug;49(4):785-788. doi: 10.1007/s15010-021-01613-w. Epub 2021 May 7.
6
[Impact of COVID pandemic on the detection of skin cancer].
Rev Med Suisse. 2021 Mar 31;17(732):635-639.
7
Management of advanced melanoma in the COVID-19 era.
Dermatol Ther. 2020 Jul;33(4):e13444. doi: 10.1111/dth.13444. Epub 2020 May 14.
8
Melanoma: A silver lining in the black cloud of COVID-19.
Dermatol Ther. 2020 Nov;33(6):e14070. doi: 10.1111/dth.14070. Epub 2020 Sep 6.
9
Impact of the COVID-19 Pandemic on Care for Patients With Skin Cancer.
Cutis. 2024 May;113(5):208-209. doi: 10.12788/cutis.1011.
10
Position statement of the EADV Melanoma Task Force on recommendations for the management of cutaneous melanoma patients during COVID-19.
J Eur Acad Dermatol Venereol. 2021 Jul;35(7):e427-e428. doi: 10.1111/jdv.17252. Epub 2021 Apr 13.
引用本文的文献
1
Decreased risk of COVID-19 and long COVID in patients with psoriasis receiving IL-23 inhibitor: A cross-sectional cohort study from China.
Heliyon. 2024 Jan 9;10(2):e24096. doi: 10.1016/j.heliyon.2024.e24096. eCollection 2024 Jan 30.
2
Impact of COVID-19 pandemic on the diagnosis of patients with skin cancer: a systematic review protocol.
BMJ Open. 2023 Mar 10;13(3):e069720. doi: 10.1136/bmjopen-2022-069720.
3
Non-Melanoma Skin Cancer: A Genetic Update and Future Perspectives.
Cancers (Basel). 2022 May 11;14(10):2371. doi: 10.3390/cancers14102371.
本文引用的文献
1
The powerful immune system against powerful COVID-19: A hypothesis.
Med Hypotheses. 2020 Jul;140:109762. doi: 10.1016/j.mehy.2020.109762. Epub 2020 Apr 22.
2
COVID-19: impact on cancer workforce and delivery of care.
Lancet Oncol. 2020 May;21(5):633. doi: 10.1016/S1470-2045(20)30240-0. Epub 2020 Apr 21.
3
Prevalence of Underlying Diseases in Hospitalized Patients with COVID-19: a Systematic Review and Meta-Analysis.
Arch Acad Emerg Med. 2020 Mar 24;8(1):e35. eCollection 2020.
4
Virtually Perfect? Telemedicine for Covid-19.
N Engl J Med. 2020 Apr 30;382(18):1679-1681. doi: 10.1056/NEJMp2003539. Epub 2020 Mar 11.
5
Clinical Characteristics of Coronavirus Disease 2019 in China.
N Engl J Med. 2020 Apr 30;382(18):1708-1720. doi: 10.1056/NEJMoa2002032. Epub 2020 Feb 28.
6
Cancer patients in SARS-CoV-2 infection: a nationwide analysis in China.
Lancet Oncol. 2020 Mar;21(3):335-337. doi: 10.1016/S1470-2045(20)30096-6. Epub 2020 Feb 14.
7
Immune Checkpoint Inhibitors in Melanoma: A Review of Pharmacokinetics and Exposure-Response Relationships.
Clin Pharmacokinet. 2019 Nov;58(11):1393-1405. doi: 10.1007/s40262-019-00789-7.
8
A case of severe Pembrolizumab-induced neutropenia.
Anticancer Drugs. 2018 Sep;29(8):817-819. doi: 10.1097/CAD.0000000000000661.
9
Chronic stress and susceptibility to skin cancer.
J Natl Cancer Inst. 2005 Dec 7;97(23):1760-7. doi: 10.1093/jnci/dji401.
Zotero 插件